Replies to post #28133 on Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

1) This preprint says we are entering the Tech Watch program, which was misworded this morning. Tech Watch is the initial entry point to "start the process" to prepare a request for BARDA funding:

"Based on these findings, aviptadil has been selected for inclusion in the Corona Virus Tech Watch Program administered by the US Department of Health and Human Services."

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228
(bottom of page 11)

AND

2) There was a nomination for the Edison award that was pulled back. No big deal here, as I think anyone can be nominated (for $1000 I believe).
https://edisonawards.com/